Nexentis Says MitoCareX Bio Expands Computational Biology Capabilities
Nexentis said MitoCareX is expanding its internal bioinformatics expertise to broaden disease-biology analysis in its computational drug-discovery activities.
Nexentis said MitoCareX is expanding its internal bioinformatics expertise to broaden disease-biology analysis in its computational drug-discovery activities.